Amsa: A phase II trial in resistant and recurrent acute myelogenous leukemia

1984 ◽  
Vol 12 (3) ◽  
pp. 178-179 ◽  
Author(s):  
Ralph Boccia ◽  
Jacob Zighelboim ◽  
Richard E. Champlin ◽  
Chun Choo Kim ◽  
Robert Peter Gale
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Trial ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia

1989 ◽  
Vol 25 (3) ◽  
pp. 223-225 ◽  
Author(s):  
Eric Archimbaud ◽  
Jacques Troncy ◽  
Catherine Sebban ◽  
Denis Guyotat ◽  
Yves Devaux ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Trial ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

scholarly journals Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia

2007 ◽  
Vol 13 (15) ◽  
pp. 4467-4473 ◽  
Author(s):  
Judith E. Karp ◽  
B. Douglas Smith ◽  
Mark J. Levis ◽  
Steven D. Gore ◽  
Jacqueline Greer ◽  
...  
Keyword(s):  
Phase Ii ◽  
Cytosine Arabinoside ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Trial ◽  
Myelogenous Leukemia ◽  
Poor Risk ◽  
Acute Myelogenous

A Phase II Study of Sequential Decitabine and Rapamycin in Acute Myelogenous Leukemia

2021 ◽  
pp. 106749
Author(s):  
Jane L. Liesveld ◽  
Andrea Baran ◽  
Mitra Azadniv ◽  
Haley Misch ◽  
Katherine Nedrow ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia

2020 ◽  
Vol 20 (4) ◽  
pp. 226-233.e1
Author(s):  
Benjamin K. Tomlinson ◽  
Molly M. Gallogly ◽  
Donna M. Kane ◽  
Leland Metheny ◽  
Hillard M. Lazarus ◽  
...  
Keyword(s):  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Wild Type ◽  
Acute Myelogenous ◽  
Unfit Patients

scholarly journals Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia

Cancer ◽  
1989 ◽  
Vol 63 (5) ◽  
pp. 813-817 ◽  
Author(s):  
Hagop M. Kantarjian ◽  
Michael J. Keating ◽  
Ronald S. Walters ◽  
Charles A. Koller ◽  
Kenneth B. McCredie ◽  
...  
Keyword(s):  
Continuous Infusion ◽  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Low Dose ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

A Phase II study of VNP40101M in elderly patients (pts) with de novo poor risk acute myelogenous leukemia (AML)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 7026-7026 ◽  
Author(s):  
G. J. Schiller ◽  
D. DeAngelo ◽  
N. Vey ◽  
S. Solomon ◽  
R. Stuart ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
De Novo ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Poor Risk ◽  
Acute Myelogenous
Sign in / Sign up

Export Citation Format

Share Document